Global Human Serum Albumin Market Growth 2025-2031

The global Human Serum Albumin market size is predicted to grow from US$ 6582 million in 2025 to US$ 9736 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

Human Serum Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

The human serum albumin (HSA) market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, HSA is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.

However, the market faces challenges such as limited plasma supply and high production costs, as HSA is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant HSA (rHSA) is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global HSA market.

The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.

LP Information, Inc. (LPI) ' newest research report, the “Human Serum Albumin Industry Forecast” looks at past sales and reviews total world Human Serum Albumin sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Serum Albumin sales for 2025 through 2031. With Human Serum Albumin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Serum Albumin industry.

This Insight Report provides a comprehensive analysis of the global Human Serum Albumin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Serum Albumin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Serum Albumin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Serum Albumin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Serum Albumin.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Serum Albumin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
20-25% Concentrations
5% Concentrations

Segmentation by Application:
Therapeutics
Excipient
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Weiguang Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Serum Albumin market?

What factors are driving Human Serum Albumin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Serum Albumin market opportunities vary by end market size?

How does Human Serum Albumin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.